No House member has disclosed a WRND trade since 2025.
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.6 | -0.5 | -7.0 | 14.0 | 5.1 | -1.9 | -1.5 | 3.5 | 1.0 | 0.7 | +17.9% | ||
| 2025 | 4.5 | 0.6 | -4.6 | -0.5 | 5.2 | 4.8 | 1.9 | 3.5 | 5.3 | 4.6 | -1.6 | -0.1 | +25.9% |
| 2024 | 0.1 | 5.7 | 3.3 | -4.1 | 4.3 | 2.5 | -0.2 | 1.5 | 1.5 | -3.1 | 0.6 | -0.2 | +12.2% |
| 2023 | 10.1 | -2.4 | 7.3 | 0.4 | 2.9 | 5.5 | 3.6 | -2.9 | -4.6 | -3.9 | 8.9 | 4.5 | +31.9% |
| 2022 | 0.2 | -8.6 | 1.8 | -8.9 | 5.9 | -5.1 | -10.8 | 3.9 | 10.4 | -5.6 | −17.6% |
The underlying index seeks to provide exposure to innovative companies by investing in the equities of companies around the world whose research and development (“R&D”) spending indicates a commitment to innovation and a focus on long-term growth. The fund will, under normal circumstances, invest at least 80% of its assets (net assets plus the amount of any borrowings for investment purposes) in equity securities determined to be R&D Leaders. The fund is non-diversified.
No recent headlines.